The Sticky Business of Noncaloric Sugars

Gilbert Levin has had sweet dreams for a long time. Levin is the president and founder of Biospherics Inc., a Beltsville, Md.-based environmental and health technology company. For nearly two decades, he has sought a noncaloric sweetener boasting both the bulk of table sugar and the ability to withstand cooking heat--in short, the ultimate food additive. Now he thinks he's found it, in a sugar called tagatose. He and the other Biospherics scientists who have studied the tagatose molecule hope

Written byMarcia Clemmit
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Now he thinks he's found it, in a sugar called tagatose. He and the other Biospherics scientists who have studied the tagatose molecule hope to prove the substance's usefulness as a noncaloric sweetener and find a cheap way to produce it in large quantities. This spring, three of the company's scientists received a patent for what they say is a low-cost method of synthesizing the sugar. Chemical compounds can exist in forms that are mirror images of each other. Like gloves, they can be either left-handed or right-handed. Sugars are such "handed" molecules. Human digestive enzymes have evolved to act upon right-handed sugar molecules, while often allowing left-handed forms to pass directly through. Both l-tagatose, the left-handed form, and d-tagatose, the right-handed form, are approximately as sweet as table sugar. Gilbert Levin's researchers at Biospherics Inc. originally investigated l-tagatose, but later they hit upon d-tagatose as a potentially better candidate. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies